IBA – ACQUISITION OF OWN SHARES Immediate Release – April 14th, 2025 Louvain-la-Neuve, Belgium, April 14th, 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until December 31st, 2025, effective as from Marc...
IBA – ACQUISITION D’ACTIONS PROPRES Publication immédiate – 14 avril 2025 Louvain-la-Neuve, Belgique, 14 avril 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 24 mars 2025. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 650.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 31 déc...
Trumps reciprocal tariffs caused a massive blow to equity markets, following a pressured period of escalating trade wars. Retaliatory measures can further heavily damage market confidence, as seen Friday when China announced their 34% tarrif of US goods. International trade policies have never moved this erratic and untransparant, with uncertainty and volatility being the baseline for now. In this report we highlight the key stocks in our coverage relevant to this discussion.
During the CMD, IBA provided some extra color on its strategic initiatives and recently issued medium-term guidance. While there is lot of information to digest, we believe management of the different divisions left a good impression on the group's strategic direction and new opportunities in the market. This while at the same time safeguarding the balance sheet and prioritizing profitability. Additionally, IBA also provided some first insights on the tariff impact, which it expects to be mild. ...
IBA – ACQUISITION OF OWN SHARES Immediate Release – April 7th, 2025 Louvain-la-Neuve, Belgium, April 7th, 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until December 31st, 2025, effective as from March ...
IBA – ACQUISITION D’ACTIONS PROPRES Publication immédiate – 7 avril 2025 Louvain-la-Neuve, Belgique, 7 avril 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 24 mars 2025. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 650.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 31 décem...
IBA long-term strategy presented at 2025 Capital Markets Day Announcement of the appointment of Catherine Vandenborre as CFO Louvain-la-Neuve, Belgium, 07 April, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, hosted its Capital Markets Day (CMD) today at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast. During the event, Olivier Legrain (CEO), Henri de Romrée (Deputy CEO), and the IBA management team outlined the company's purpose, vision, and strategy to shareholders, investors, and analysts. They also presented ...
IBA a présenté sa stratégie à long terme lors de son Capital Markets Day 2025 Annonce de la nomination de Catherine Vandenborre au poste de CFO Louvain-la-Neuve, Belgique, le 7 avril 2025 - IBA (Ion Beam Applications S.A., EURONEXT), leader mondial de la technologie des accélérateurs de particules, a organisé aujourd'hui un Capital Markets Day (CMD) à son siège social de Louvain-la-Neuve, Belgique, et via webcast. Lors de l'événement, Olivier Legrain (CEO), Henri de Romrée (Deputy CEO) et l'équipe de direction d'IBA ont présenté aux actionnaires, investisseurs et analystes la mission, la ...
IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day Louvain-la-Neuve, Belgium, 04 April, 2025 – (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming Monday 7 April from 2pm to 5:00pm CEST (8am ET to 11:00am ET) at its headquarters in Louvain-la-Neuve, Belgium, and via live webcast. At the event IBA’s management team will outline the company’s strategic roadmap and long-term growth ambitions. The agenda is outlined below: Webcast open: 2pmPurpose, Vision & StrategyBu...
IBA présente sa stratégie de croissance à long terme lors de son Capital Markets Day 2025 Louvain-la-Neuve, Belgique, le 4 avril 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules, organise un Capital Markets Day (CMD-journée investisseurs) ce lundi 7 avril de 14h à 17h00 heure de Bruxelles (8h à 11h00 heure de Washington) à son siège à Louvain-la-Neuve et via un webcast. Lors de cet événement, la direction de la société présentera la feuille de route stratégique de l'entreprise et ses ambitions de croissance à long terme. L...
IBA signs contract for a Proteus®ONE solution to be installed at the Tri-Service General Hospital in Taiwan Louvain-La-Neuve, Belgium, April 2nd, 2025 – (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the supply of a Proteus®ONE1 compact proton therapy solution to be located at the Tri-Service General Hospital in Taipei, Taiwan. The contract includes the supply of a Proteus®ONE system and a Quality Assurance...
IBA signe un contrat pour installer une solution Proteus®ONE au Tri-Service General Hospital à Taïwan Louvain-la-Neuve, Belgique, le 2 avril 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie pour le traitement du cancer, annonce aujourd'hui la signature d'un contrat pour la fourniture d'une solution compacte de protonthérapie Proteus®ONE1 au Tri-Service General Hospital à Taipei, Taïwan. Le contrat comprend la fourniture d'un système Proteus®ONE et d'un package d'ass...
IBA – ACQUISITION OF OWN SHARES Immediate Release – March 31st, 2025 Louvain-la-Neuve, Belgium, March 31st, 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until December 31st, 2025, effective as from Marc...
IBA – ACQUISITION D’ACTIONS PROPRES Publication immédiate – 31 mars 2025 Louvain-la-Neuve, Belgique, 31 mars 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique par la présente certaines informations relatives à son programme de rachat d'actions annoncé le 24 mars 2025. Dans le cadre de ce programme, IBA a demandé à un intermédiaire financier de racheter en son nom un maximum de 650.000 actions ordinaires IBA selon les termes d'un mandat valable jusqu'au 31 décem...
This note gathers feedback from the group meetings and the panels. In total 21 companies were presented in group meetings and/or panels. More than 100 guests found their way to the venue either physical or virtual (only panels). The 2 panels made for informative additions to the C-level meetings and a nice platform for discussion. Wednesday afternoon concentrated 4 experts from Logistic companies (CTP, Montea, VGP, WDP) for an interesting discussion on brownfields: " an answer to the scarcity of...
IBA – Rachat d’actions propres Louvain-la-Neuve, Belgique, 24 mars 2025 - Ion Beam Applications SA (IBA) a annoncé aujourd’hui le lancement d’un programme de rachat d’actions propres à compter du 25 mars 2025, en application de l’article 7:215 du Code belge des sociétés et des associations. Par décision du conseil d’administration du 18 mars 2025, prise en exécution de l’autorisation donnée par l’AGE du 4 septembre 2023, IBA a lancé un programme de rachat d’actions propres au travers d’un mandat donné à un intermédiaire de marché. Ce programme porte sur un maximum de 650.000 actions ord...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.